You are viewing the site in preview mode

Skip to main content

Development and validation of simple colorimetric methods for assessing norfloxacin in pure form, in pharmaceutical products and in biological material

Abstract

Two straightforward, affordable, accurate, and spectrophotometric techniques gross developed to assess norfloxacin, formulations, and biological samples. The oxidation of norfloxacin will be done in technique (A) in acid solution with help of Fe(III). A wavelength of 511 nm with a correlation coefficient of 0.9879 was produced by the resulting Fe(II) coupled with 1,10-phenanthroline and the red colour complex. A uniform absorbance ranging from 1 to 30 µg/mL was discovered. Similarly, in procedure (B), in an acidic medium, Ce(IV) was added to norfloxacin. After reacting with a specific amount of methyl orange, the residual Ce(IV) is then determined. An absorbance measurement at 508 nm and a correlation coefficient of 0.9966 indicate a straight-line relationship between the two variables for concentration range is 1–15 µg/mL. The procedures were developed after a careful analysis of the several elements that influence the reaction process. After calculations, the LOD (limits of detection) and LOQ (limit of quantification) were determined to be 1.098 and 1.111 µg/mL for method A and 2.875 and 3.368 µg/mL for method B respectively. The method B has also been applied for the determination of norfloxacin in spiked human plasma and urine samples. The percentage recoveries ranged from 98.74 to 103.43% and from 98.17 to 100.85% for plasma and urine samples, respectively. Proposed techniques have been successfully used for the examination of biological fluids, formulations for medicines as well as pure norfloxacin following statistical validation through recovery studies.

Peer Review reports

Introduction

Antimicrobial medicines called quinolones are commonly used to treat infections in both people and animals. These drugs are essential for treating diseases of the respiratory system, skin, and urinary tract. Nalidixic acid is the precursor to the broad-spectrum synthetic antibacterial class drugs called fluoroquinolones. Their primary use since their accidental discovery in 1962 has been to treat a variety of infectious diseases [1,2,3,4]. Fluoroquinolones are efficiently absorbed by the digestive system. They are capable of good extended elimination half-lives, tissue penetration, and low protein binding. Adults can tolerate these antibiotics well and they can be used to treat a wide range of infections [5, 6]. Norfloxacin (NFX), made from fluoroquinolone carboxylic acid, is prescribed to treat urinary tract and respiratory infections [7]. Rapid and precise analytical methods are needed to identify NFX because of its extensive use as well as the necessity of clinical and medical research.

There are several methods for NFX analysis in various pharmacological preparations and biological materials. High pressure liquid chromatography [8,9,10], thin layer chromatography [11], liquid chromatography [12], voltammetric technique [13], DPP [14], fluorometry [15] as well as PT [16] are few of given approaches. For identifying (NFX), most of published studies on spectrophotometric [17,18,19,20,21] approaches include a lot of steps, expensive reagents, poor selectivity, and low linear ranges. Some of the approaches are completely described in the literature. Spectrophotometry is taken into consideration as the preeminent analytical methods for studying allopathic products due to its accessibility, affordability, and availability. Goal of the manuscript is to introduce two simple, inexpensive, rapid, accurate, and environmentally unaffected techniques that enable excellent sensitivity and high reproducibility of (NFX) detection.

Experimental

Reagents and material

Every reagent used was of the higher quality and utilized straight away, without further purification. The given supplies have been used in the scheme: Methyl orange (MO) (Fisher Chemical UK Limited), 1,10-phenanthroline (Scharlau Chemi S. A., Barcelona, Spain), methanol (Merck, Darmstadt, Germany), H2SO4 (Riedel-deHaen, Germany), 95 − 77% pure FeCl3 × 6H2O, and 65% nitric acid (Sigma-Aldrich). The standard reference norfloxacin was providing by the pharmaceutical manufacturer. Noroxin tablets 400 mg (manufactured by OBS Pakistan (Pvt) Ltd, C-4 S.I.T.E, Karachi), (Utinor tablets 400 mg, manufactured by Standpharm Pakistan (Pvt) LTD), Alenbit tablets 400 mg, manufactured by Meezab International, Karachi, Pakistan and Norocin tablets 400 mg manufactured by Bosch Pharmaceutical Pvt) Ltd. Korangi Industrial Area Karachi Pakistan) were purchased locally.

Instruments

Shimadzu UV-1800, ENG 240 V dual beam spectrophotometer with 1 cm quartz cells were employed to determine the absorbance. Additionally, a water bath is used and digital analytical balance (OHAUS Corporation USA).

Preparation a solution of reagents

FeCl3.6H2O (0.054 g) dissolved in water that had been deionized to create 0.002 mol/L Fe(III) solution, and then further diluted to 100 mL. 0.0594 g of the reagent was dissolved in 5.0 mL of ethanol to create 0.006 mol/L 1,10-phenanthroline solution, and then diluted it further using distilled water, up to about 50 mL.

Nitric acid 8.02 mL solution in 50 mL of distilled water was used to create 2.5 mol/L. Similarly, 0.0606 g of Ce(SO4)2.4H2O was added to 50 mL of 2.5 mol/L nitric acid, and the mixture was diluted with deionized water until it reached 50 mL. This resulted in a 3.0 × 10− 3 mol/L Ce(IV) solution. 0.1304 g MO was dissolved in distilled water (50 mL) to create an 8 × 10− 3 mol/L solution.

Making standards

0.005 g of standard norfloxacin was dissolved in 50 mL distilled water by heating at 60 °C on a water bath to make a stock solution of 100 µg/mL. To make new standard solutions with the necessary concentrations, the stock solution was diluted with deionized water every day before use.

Suggested method for calibration curve construction

Method-A: NFX stock solution was added in the proper amounts to separate test tubes till an ultimate concentration of 1–30 µg/mL is achieved. 10 mL of deionized water was used to dilute the mixtures after 1.5 mL of 0.014 mol/L 1,10-phenanthroline and after adding 0.002 mol/L Fe3+ solution about 0.5 mL, the mixture was heated using water bath for 15 min at 100 oC. Spectrophotometer was used to detect the ratio of absorbance at 511 nm to a reagent blank that had been precisely replicated from drug sample.

Method-B: 10 milliliter volumetric flasks were filled with diluted norfloxacin stock solutions of the appropriate volumes, making the ultimate concentration ranging from1 and 20 µg/mL. Then they were filled with 2.5mL of 2.5 mol/L nitric acid and 1.5mL of 3.0 × 10− 3mol/L Ce(IV). Flasks remained left alone for 15 min while being continuously shaken, followed by the addition of 1.5 mL of 8.0 × 10− 3 mol/L MO solution. Each solution’s absorbance at 508 nm is measured in contrast to a reagent blank that was the same but did not contain the drug.

Application to pharmaceutical formulations

The contents of four 400 mg tablets—Norocin, Utinor, Noroxin, and Alenbit—were weighed individually to determine the mean weight of one tablet. Next, 100 µg/mL solution was prepared by dissolving 0.005 g of norfloxacin powder in distilled water while being shaken. Following filtering, 50 mL volumetric flasks were filled with the resultant solutions, and deionized water was used to adjust the contents. Next, the accurate amount of this stock solution was created by diluting 100 µg/mL norfloxacin solution. To ascertain the precise norfloxacin content of the provided sample, following that, using the methods described to create the calibration curve, the volumes of these solutions were examined.

Application to biological fluids

The method B can also be applied for the biological fluids. 1 mL of blood plasma or urine was mixed with 6 mL of acetonitrile and 2.5 mL of standard norfloxacin in a test tube and placed in centrifuge tube. The mixture was centrifuge for 10 min at 3500 rpm. After deproteinization clear liquid was diluted to 25 mL with distilled water in volumetric flask. Then 1, 2 and 3 µg/mL of drug were taken in three separate 10 mL volumetric flasks and added all the optimized reagents and allowed to stand for 15 min and then diluted to 10 mL with distilled water and absorbance was measured at 508 nm.

Outcome and discussion

Method-A: Ferric salt is an essential part of the analysis of pharmaceutical drugs; the concentration of the drug is indicated by the amount of ferric salt that oxidizes to ferrous salt. The drug’s decrease of Fe(II) is considered using 1,10-phenonthroline, and a spectrophotometric technique can be developed using this property that measures NFX in pharmaceutical formulations. Norfloxacin reacts with 1,10-phenonthroline and Fe(III) to form tris(1,10-phenonthroline) iron(II) chelate, an orange-red color complex with a maximum absorbance of 511 nm (Fig. 1A).

Fig. 1A
figure 1

Absorption spectrum of norfloxacin (a), Absorption spectrum of color complex (b). Condition: 1.0 mL of Fe3+ (0.002 mol/L), 30 µg/mL of norfloxacin, 1.0 mL of 1,10-phenanthroline (0.006 M), heated at 100 ° C for 15 min, diluted to 10 mL

For Method B: Using spectrofluorimetric [22,23,24], spectrophotometric [25,26,27] and chemiluminescence [28] methods, a variety of medicinal compounds have been identified, Ce(IV) is utilized as an oxidizing agent in each of them. The proposed method is based on the addition of Ce(IV) to norfloxacin in acidic medium, followed by measuring the residual Ce(IV) by reacting with methyl orange and the absorbance was measured at 508 nm (Fig. 1B(c)). As shown in Fig. 1B(a), the norfloxacin show very low absorbance in the ultraviolet region. The Fig. 1B(b) show the absorption spectra of Ce(IV) and methyl orange. The Fig. 1B(c) show the absorbance spectra of Norfloxacin-Ce(IV) and methyl orange.

Fig. 1B
figure 2

Absorption spectra of (a) Norfloxacin, (b) Ce(IV)-Methyl orange, (c) Norfloxacin-Ce(IV)-Methyl orange. Condition: 20 µg/mL of norfloxacin, 3.0 × 10− 3molL − 1 of cerium(IV), and 8 × 10− 3 mol/L of MO

Optimization of reaction conditions

Several distinct experimental conditions that impact the results of both techniques development and stability of color products formation were thoroughly analyzed and optimized. One by one, these characteristics were altered while the others stayed the same.

Method-A

Impact of heating time and temperature

Effects of duration and temperature on complexation reaction were examined. At temperatures between 60 and 100oC, the effects of heating times ranging from 5 to 30 min were investigated. Based on the findings, it was determined that heating the reaction to 100 oC for around 15 min increased the amount of color creation (Figs. 2 and 3).

Fig. 2
figure 3

Temperature’s impact on norfloxacin’s spectrophotometric characteristics

Fig. 3
figure 4

Effect of heating time on the determination of norfloxacin

Effect of concentration and volume of Fe3+ solution

The effect of Fe3+ concentration was investigated in the range of 0.001–0.005 mol/L (Fig. 4). A 0.002 mol/L Fe3+ solution was found to form the most colorful formation.

The influence of the total amount at 0.002 mol/L of the Fe3+ solution has been investigated by the addition of various concentrations of Fe3+. The solution with the highest absorbance, 0.5 mL, was used.

Fig. 4
figure 5

Effect of Fe(III) concentration on the norfloxacin determination

Impact of 1,10-phenanthroline solution’s concentration and volume

Effect of 1,10-phenanthroline has been studied in the 0.002–0.018 mol/L range, as well as the influence of the solution’s volume and to produce colored complexes.

A 1,10-phenanthroline solution was found to achieve the highest absorbance at 0.014 mol/L (Fig. 5). To investigate the effect of the volume of the solution, several mL of 1,10-phenanthroline (0.014 mol/L) were added. Solution’s maximum capacity for absorption was measured using 1.5mL.

Fig. 5
figure 6

Effect of concentration of 1,10 phenanthroline

Reaction product’s stability

For up to two hours, absorbance measurements were taken every 10 min to assess reaction product’s stability.

The product’s absorbance remained unchanged. Absorbance stays constant and has no effect on the results of the analysis, even if it is tested two hours after the dilution (Fig. 6).

Fig. 6
figure 7

Time’s impact on the colored product’s stability

Method-B

Effects of acid concentration and kind

To prevent the precipitation of hydrated ceric oxide (CeO2.H2O), an acidic media was used for the oxidation reaction. A range of acids, such as H2SO4, HNO3, and HCl, were examined to ascertain which ones would be most effective for a reaction. The greatest amount of colour was produced by HNO3 (2.5 mL of 2.5 mol/L).

Impact of Ce (IV) concentration

Outcomes of Ce(IV) concentrations that vary from 1 × 10− 3 to 5 × 10− 3 mol/L were examined in this study. The higher colour product formation was observed in the 3 × 10− 3 mol/L Ce(IV) solution (Fig. 7). The volume of the Ce(IV) solution is optimized, the highest creation of products takes place with 1.5mL of Ce(IV) solution (3 × 10− 3 mol/L).

Fig. 7
figure 8

Cerium (IV) concentration’s effect

Effect of MO concentration

Effect of various MO concentrations were investigated between 2 × 10− 3 and 1.2 × 10− 2 mol/L. The highest color production was seen in Fig. 8 when 8 × 10− 3mol/L MO has been employed. Additionally, result of the methyl orange solution’s volume has been studied, as well as and 1.5 mL of 8 × 10− 3 mol/L MO solution was determined to have the highest absorbance.

Fig. 8
figure 9

Impact of concentration of MO

Analytical figures of merit

In ideal experimental circumstances for suggested techniques, the study demonstrates a linear connection between norfloxacin absorbance and concentration. Technique A demonstrated an excellent correlation coefficient of 0.9879 within range of concentrations of 1–30 µg/mL, method B, on the other hand, showed a significant correlation coefficient of 0.9966. The findings show that Beer’s law is followed.

Techniques A and B’s calibration curves for the measurement of NFX are displayed in Figs. 9 and 10, respectively. The LOD, which was calculated using the least amount (3.3 × (Sy/S)) at which NFX can be consistently recognized, remained found to be 1.098 µg/mL for approach A and 1.111 µg/mL for approach B.

Using lowest norfloxacin concentration (10 × (Sy/S)) that could be measured with high accuracy and precision to estimate the LOQ; for technique A, this was 2.875 µg/mL, and for method B, it was 3.368 µg/mL. Intercept, relative standard deviation, λ max, slope, linear regression equation, standard deviation, correlation coefficient, and molar absorptivity are among the optical characteristics of for method A and method B are listed in Table 1.

Fig. 9
figure 10

Norfloxacin concentration’s impact on absorbance. Conditions: 1–30 µg of norfloxacin per milliliter with a λmax of 511 nm, Subsequently, 15 min of heating at 100 °C, 1.0 mL of Fe3+ (0.002 mol/L), 1.5 mL (0.014 mol/L), as well as 1,10 phenanthroline were diluted to 10 mL

Fig. 10
figure 11

Norfloxacin concentration’s impact on absorbance. Conditions; The mixture contained Ce(IV) (1.5 mL; 3.0 × 10− 3 mol/L), MO (1.5 mL; 8.0 × 10− 4 mol/L), Norfloxacin (1–15 µg/mL), and HNO3 (2.5 mL; 2.5 mol/L). It had a λmax of 508 nm after being diluted to 10 milliliters

Table 1 Spectrophotometric methods’ analytical parameters for measuring norfloxacin

Specificity of the methods

Using recommended methods for measuring norfloxacin in pharmaceutical formulations containing antibiotic, the degree of selectivity was demonstrated. The interference brought on by widely utilized excipients such as glucose, sorbitol, lactose, fructose, starch, and Mg stearate has been also investigated.

Fixed amount of NFX solution was mixed with one excipient in every following ratio: 1:1, 1:2, 1:4, 1:6, 1:8, 1:10, and 1:20. The recommended procedure was then used to inspect the mixture. It was discovered that these excipients did not interfere with anything (Fig. 11).

Fig. 11
figure 12

Effects of common excipients on the recommended methods for determining norfloxacin

Reliability

Through triplicate measurements of NFX in both pure form and at three distinct concentration levels and pharmaceutical formulations that adhere to Beer’s law, the precision of the recommended techniques was shown. The results for pure form are listed in Table 2 and for pharmaceutical preparations are listed in Table 3. The methods’ low relative standard deviation values and good % recoveries show their great accuracy and exceptional precision.

The percentage recoveries for the standard for procedure A and B obtained were ranged from 96.80 to 102.30% and from 97.94 to 101.94% respectively. Similarly, the percent recoveries for pharmaceutical formulations for method A and B ranged from 95.74 to 102.53% and 98.06 to 104.44% respectively. Using four different brands of 400 mg NFX pills (Norocin, Utinor, Alenbit, and Noroxin), the standard addition method was also used to assess the procedure’s accuracy. The recommended procedures were followed, and tablet solutions were combined with predetermined amounts of standard norfloxacin solution.

Percent recoveries for methods A and B ranged from 98.00 to 102.19% and 98.0–102.0%, respectively. The standard addition method compensates for the influence of the matrix by adding known quantities of the analyte to the sample. Used to determine the concentration of an analyte in samples with complex or unknown matrices, such as biological fluids, environmental samples, or food products. The recoveries were computed by comparing the outcomes prior to and following the addition of standard NFX solution (Table 4). To test technique B’s accuracy, a recovery experiment was carried out using tampered-with plasma and urine samples. The percentage recoveries for plasma and urine samples varied from 98.74 to 103.43% and 98.17–100.85%, respectively (Table 5).

Table 2 The suggested methods’ accuracy and precision when utilizing a standard norfloxacin solution
Table 3 Evaluation of the current techniques’ accuracy and precision in detecting norfloxacin in pharmaceutical formulations
Table 4 Standard addition method evaluation of norfloxacin recovery percentage in commercial formulations
Table 5 Percentage of norfloxacin recovered using method B from spiked plasma and urine samples

Applicability of the proposed methods

Four distinct pharmaceutical brands’ levels of norfloxacin were successfully measured using the accepted methods. The suggested approach is a helpful tool for determining the amount of norfloxacin in pharmaceutical items, as showed by the results of the commended techniques that closely correspond to the label values (Table 6).

The methods’ great selectivity and the lack of common excipient interference made them effective for detecting NFX in tampered-with human urine and plasma.

Table 6 Determination of norfloxacin in pharmaceutical preparations

Conclusions

Using a variety of components, two sensitive, quick, economical, and selective approaches were generated to measure NFX in biotic samples as well as pharmaceutical preparations. It has been concluded that the proposed technique can precisely and accurately determine NFX concentrations down to 1 µg/mL and has a wider linear range. Time-consuming extraction processes and preparation are not necessary for the established methods, in contrast to other chromatographic and reported spectrophotometric approaches. The methods utilize affordable chemicals and easily accessible equipment. Furthermore, excipients commonly found in pharmaceutical formulations had no effect on the analysis. The techniques’ high reproducibility and good recovery make them a valuable substitute for the numerous additional techniques currently employed to measure the amounts of NFX in commercial tablet formulations.

Data availability

No datasets were generated or analysed during the current study.

References

  1. Bertino J, Fish D. Safety profiles of the fluoroquinolones. Clin Ther Hillsborough. 2000;22:798–817.

    CAS  Google Scholar 

  2. Fierens C, Hillaert S, Bossche WVD. The qualitative and quantitative determination of quinolones of first and second generation by capillary electrophoresis. J Pharm Biomed Anal. 2000;22:763–72.

    CAS  PubMed  Google Scholar 

  3. Marzo A, Dal Bo L. Chromatography as an analytical tool for selected antibiotic classes: a reappraisal addressed to pharmacokinetic applications. J Chromatogr A. 2002;812:17–34.

    Google Scholar 

  4. Arteseros JAH, Barbosa J, Compano R, Prat MD. Analysis of quinolone residues in edible animal products. J Chromatogr Amsterdam. 2002;945:1–24.

    Google Scholar 

  5. Tsai TH, Wu JW. Pharmacokinetics of ciprofloxacin in the rat and its interaction with cyclosporin A: a microdialysis study. Anal Chim Acta. 2001;448(1–2):195–9.

    CAS  Google Scholar 

  6. Holtzapple CK, Buckley SA, Stanker LH. Determination of fluoroquinolones in serum using an on-line clean-up column coupled to high-performance immunoaffinity–reversed-phase liquid chromatography. J Chromatogr B Biomed Sci Appl. 2001;754(1):1–9.

    CAS  PubMed  Google Scholar 

  7. Zeiler HJ, Grohe K. The in vitro and in vivo activity of ciprofloxacin. Eur J Clin Microbiol. 1984;3:339–43.

    CAS  PubMed  Google Scholar 

  8. Samanidou VF, Demetriou CE, Papadoyannis IN. Direct determination of four fluoroquinolones, enoxacin, norfloxacin, ofloxacin, and ciprofloxacin, in pharmaceuticals and blood serum by HPLC. Anal Bioanal Chem. 2003;375:623–9.

    CAS  PubMed  Google Scholar 

  9. Calucci G, Mazzeo P, Paumbo G. A high performance liquid chromatographic procedure for the simultaneous determination of norfloxacin and furprofen in rat plasma. Biomed Chromatogr. 1993;7(3):126–8.

    Google Scholar 

  10. Delepine B, Hurtaud-Pessel D, Sanders P. Simultaneous determination of six quinolones in pig muscle by liquid chromatography-atmospheric pressure chemical ionisation mass spectrometry. Analyst. 1998;123:2743–7.

    CAS  PubMed  Google Scholar 

  11. Wang P, Feng Y, Chen L. Simultaneous determination of trace norfloxacin, pefloxacin and ciprofloxacin by TLC fluorescence spectrodesitometry. Microchemical J. 1997;56(2):229–35.

    CAS  Google Scholar 

  12. Hing-Biu L, Peart TE, Svoboda ML. Determination of ofloxacin, norfloxacin, and ciprofloxacin in sewage by selective solid-phase extraction, liquid chromatography with fluorescence detection, and liquid chromatography–tandem mass spectrometry. J Chromatogr A. 2007;1139:45–52.

    Google Scholar 

  13. Ghoneim MM, Radi A, Beltagi AM. Determination of norfloxacin by squarewave adsorptive voltammetry on a glassy carbon electrode. J Pharm Biomed Anal. 2001;25:205–10.

    CAS  PubMed  Google Scholar 

  14. Jaber AMY, Lounici A. Adsorptive differential-pulse stripping voltammetry of norfloxacin and its analytical application. Analyst. 1994;119:2351–7.

    Google Scholar 

  15. Vleiopoulo CJ, Ioannou PC, Lianidou ES. Application of terbium sensitized fluorescence for the determination of fluoroquinolone antibiotics pefloxacin, ciprofloxacin and norfloxacin. J Pharm Biomed Anal. 1997;15(12):1839–44.

    Google Scholar 

  16. Mandil HH, Sakur AA, Nasser B. Use of cerium(IV) in potentiometric titration of norfloxacin in pharmaceutical preparations. Asian J Chem. 2012;24:2985–8.

    CAS  Google Scholar 

  17. Rajendra PA, Ratna JV. Ultraviolet-spectrophotometric method development and validation for the determination of norfloxacin present in taste masked drug resin complex. Asian J Pharm Clin Res. 2018;11(4):244–7.

    Google Scholar 

  18. Rahman N, Ahmad Y, Azmi SNH. Kinetic spectrophotometric method for the determination of norfloxacin in pharmaceutical formulations. Eur J Pharm Biopharm. 2004;57(2):359–67.

    CAS  PubMed  Google Scholar 

  19. Darwish I, Sultan M, Al-Arfaj H. Novel selective kinetic spectrophotometric method for determination of norfloxacin in its pharmaceutical formulations. Talanta. 2009;78:1383–8.

    CAS  PubMed  Google Scholar 

  20. Gaber M, Khedr AM, El-Kady AS. Spectrophotometric determination of norfloxacin in pure and dosage forms by complexation with Fe(III) and Cu(II) ions. Int Res J Pharm Pharmacol. 2012;2(5):97–102.

    Google Scholar 

  21. Chierentin L, Salgado HRN. Performance characteristics of UV and visible spectrophotometry methods for quantitative determination of norfloxacin in tablets. J Sci Res. 2014;6(3):531–41.

    CAS  Google Scholar 

  22. Shah J, Jan MR, Khan MN. Inayatullah. Spectrofluorimetric method for quantification of citalopram in pharmaceutical preparations and biological fluids through oxidation with Ce(IV). J Appl Spectros. 2013;79:922–8.

    CAS  Google Scholar 

  23. Shaalan RA. Improved spectrofluorimetric methods for determination of penicillamine in capsules. Cent Eur J Chem. 2010;8(4):892–8.

    CAS  Google Scholar 

  24. Tabrizi AB. A simple spectrofluorimetric method for determination of piroxicam and propranolol in pharmaceutical preparations. J Food Drug Anal. 2007;15(3):242–8.

    CAS  Google Scholar 

  25. Rajendraprasad N, Basavaiah K. Highly sensitive spectrophotometric determination of olanzapine using cerium (IV) and iron (II) complexes of 1,10-phenanthroline and 2, 2′-bipyridyl. J Anal Chem. 2010;65:482–8.

    CAS  Google Scholar 

  26. Devi OZ, Basavaiah K, Revanasiddappa HD, Vinay KB. Titrimetric and spectrophotometric assay of pantoprazole in pharmaceuticals using cerium(IV) sulphate as oxidimetric agent. J Anal Chem. 2011;66(5):490–5.

    CAS  Google Scholar 

  27. Khan MN, Ahmad J, Jan MN, Gulab H, Idrees M. Development and validation of a new spectrophotometric method for the determination of cephalexin monohydrate in pure form and pharmaceutical formulations. J Braz Chem Soc. 2016;27(5):912–8.

    CAS  Google Scholar 

  28. Aly FA, Al-Tamimi SA, Alwarthan AA. Chemiluminescence determination of some fluoroquinolone derivatives in pharmaceutical formulations and biological fluids using [Ru(bipy)32+]–Ce(IV) system. Talanta. 2001;52:885–93.

    Google Scholar 

Download references

Acknowledgements

The authors extend their appreciation to the Researchers Supporting Project number (RSPD2025R941), King Saud University, Riyadh, Saudi Arabia.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

Muhammad Adnan, Muhammad Naeem Khan, and Nusrat Bibi: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data; Wrote the paper. Muhammad Adnan, Iftikhar Ali, Asif Kamal, Abd El-Zaher M.A. Mustafa, Muhammad Naeem Khan: Conceived and designed the experiments; Performed the experiments; Contributed reagents, materials, analysis tools or data; Wrote the paper. Muhammad Adnan, Muhammad Naeem Khan, Abd El-Zaher M.A. MustafaNusrat Bibi, Muhammad Adnan, Asif Kamal, Muhammad Naeem Khan: Conceived and designed the experiments; Contributed reagents, materials, analysis tools or data; Wrote the paper.

Corresponding authors

Correspondence to Muhammad Naeem Khan or Muhammad Adnan.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

All authors agree to publish the article.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khan, M.N., Adnan, M., Bibi, N. et al. Development and validation of simple colorimetric methods for assessing norfloxacin in pure form, in pharmaceutical products and in biological material. BMC Pharmacol Toxicol 26, 75 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40360-025-00916-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40360-025-00916-0

Keywords